lung cancer

January 31, 2017January 31, 2017

Anxiety, Depression May Increase Mortality Among Lung Cancer Patients

Lung Cancer, News

Patients who are diagnosed with cancer can experience significant emotional distress. Now a study has shown that anxiety and depression may increase mortality among patients who have advanced lung cancer. ... Read more

January 19, 2017January 19, 2017

New Removable Stent Shows Potential for Pulmonary Medicine

Lung Cancer, News

A new type of removable stent, created in 2015 for use in blood vessels, shows potential to also be used in the respiratory tract, which could transform treatment for patients who are ... Read more

January 9, 2017January 9, 2017

Older Patients with Non-small Cell Lung Cancer Face Significant Challenges After Treatment, Study Shows

Lung Cancer, News

Older patients with early non-small cell lung cancer (NSCLC) can spend an average of one in three days interacting with the healthcare system during the initial 60 days after treatment — either ... Read more

December 15, 2016December 15, 2016

LUNGevity Presents Research on Lung Cancer Treatments, Patient Preferences

Lung Cancer, News

LUNGevity Foundation, a nonprofit lung cancer organization, recently presented four of its research abstracts regarding patient preferences and treatment options were presented at this year’s International Association for the Study of Lung Cancer ... Read more

October 24, 2016October 24, 2016

FDA Approves Tecentriq Immunotherapy for Specific Type of Advanced Lung Cancer

Lung Cancer, News

The U.S. Food and Drug Administration (FDA) approved Genentech’s Tecentriq (atezolizumab) as a treatment for people with metastatic non-small cell lung cancer (NSCLC). The drug is specifically indicated for NSCLC patients whose ... Read more

October 7, 2016October 7, 2016

NICE Acts to Make Tagrisso Available to Patients in UK with Agressive Lung Cancer

Lung Cancer, News

The National Institute for Health and Care Excellence (NICE) has issued a final draft guidance recommending Tagrisso (osimertinib) be made available within the National Health Service (NHS) in England and Wales to treat a particularly aggressive form ... Read more

October 3, 2016October 3, 2016

American Lung Association ‘Freedom from Smoking’ Videos to Air at 25,000 Clinics

Asthma, COPD, Lung Cancer, News

ContextMedia:Health and the American Lung Association (ALA) partnered to deliver lung health information through original video content, presenting the “Freedom from Smoking” online cessation program. ContextMedia:Health is a provider of digital solutions at ... Read more

September 26, 2016September 26, 2016

Inventiva Receives €2.3 Million to Support YAP/TEAD Protein Research Program

Lung Cancer, News

Inventiva has been awarded two grants totaling €2.3 million ($2.58 million) to further its YAP/TEAD protein research program, which focuses on developing molecules with the potential to treat severe forms of lung, ... Read more

September 23, 2016September 23, 2016

Genentech’s Tecentriq Seen to Significantly Increase Survival in Patients with Specific Type of Lung Cancer

Lung Cancer, News

Genentech recently announced positive results for its cancer immunotherapy Tecentriq (atezolizumab) being tested in the Phase 3 clinical trial OAK (NCT02008227). Tecentriq is a monoclonal antibody designed to bind to an immune checkpoint protein ... Read more

August 18, 2016August 18, 2016

Lung Cancer Type and Severity Better Seen by Computers Than Pathologists, Study Reports

Lung Cancer, News

Computer analysis of slides containing lung cancer tissue samples increases the accuracy of tumor classification and patient prognoses, according to a new study conducted at Stanford University School Of Medicine in ... Read more